Loading clinical trials...
Loading clinical trials...
Symptom Clusters and Risk Factors of Patients Recovering From COVID-19 Caused by Omicron BA.2
Conditions
Locations
1
China
Shanghai Jiaotong University School of Medicine, Renji Hospital
Shanghai, Shanghai Municipality, China
Start Date
May 15, 2022
Primary Completion Date
June 2, 2022
Completion Date
June 2, 2022
Last Updated
September 27, 2022
NCT07221162
NCT06082518
NCT06631287
NCT06679140
NCT06417762
NCT03830320
Lead Sponsor
RenJi Hospital
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions